arginyl-glycyl-aspartyl-serine has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, I; Kojima, M; Komazawa, H; Nishi, N; Nishikawa, N; Ono, M; Saiki, I; Tokura, S; Yoneda, J; Yoo, YC | 1 |
| Miller, RJ; Murthy, MS; Scanlon, EF; Trueheart, R; Weiss, BD | 1 |
2 other study(ies) available for arginyl-glycyl-aspartyl-serine and Liver Neoplasms
| Article | Year |
|---|---|
Inhibition of tumor metastasis by Arg-Gly-Asp-Ser (RGDS) peptide conjugated with sulfated chitin derivative, SCM-chitin-RGDS.
Topics: Amino Acid Sequence; Animals; Cell Adhesion; Chitin; Liver Neoplasms; Lung Neoplasms; Lymphoma; Melanoma, Experimental; Mice; Molecular Sequence Data; Neoplasm Metastasis; Neoplasms, Experimental; Oligopeptides | 1993 |
Inhibition of tumor implantation at sites of trauma by Arg-Gly-Asp containing proteins and peptides.
Topics: Animals; Female; Liver; Liver Neoplasms; Lung Injury; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Neoplasm Transplantation; Oligopeptides; Proteins | 1992 |